Advertisement
BillionToOne, Inc.

BillionToOne, Inc. (BLLN) Stock Overview

Explore BillionToOne, Inc.’s financial performance, market position, analyst ratings, and future outlook.

BLLNNASDAQ
HealthcareMedical - Diagnostics & Research
$99.66
$5.23(5.54%)
U.S. Market is Open · 13:28
Advertisement

BillionToOne, Inc. (BLLN)

Meyka AI Score

Z

Key Financials

Market Cap4.7B
P/E Ratio180.87
EPS (TTM)$0.53
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

BLLN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BillionToOne, Inc. (BLLN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 56.37, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 180.87 and a market capitalization of 4.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.06%
5-Day Change
-4.17%
1-Month Change
6.78%
3-Month Change
41.40%
6-Month Change
-4.28%
Year-to-Date (YTD) Change
21.29%
1-Year Change
-8.89%
3-Year Change
-8.89%
5-Year Change
-8.89%
All-Time (Max) Change
-8.89%

Contact Information

(650) 460-2551
1035 O’Brien Drive, Menlo Park, CA, 94025

Company Facts

6,200 Employees
IPO DateNov 6, 2025
CountryUS
Actively Trading

Frequently Asked Questions